DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today the approval of non-qualified stock option (“Options”) and restricted stock unit (“RSUs”) grants to Inspire’s Executive Vice President and Chief Administrative and Legal Officer, Andrew I. Koven, pursuant to NASDAQ Marketplace Rule 5635(c)(4).
